• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制疗法治疗老年获得性纯红细胞再生障碍:环孢素 A 可能更有效。

Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective.

机构信息

Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, 300# Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.

The First Affiliated Hospital of Jilin University, 71# Xinming Street, Changchun, 130021, Jilin Province, China.

出版信息

Ann Hematol. 2020 Mar;99(3):443-449. doi: 10.1007/s00277-020-03926-6. Epub 2020 Jan 22.

DOI:10.1007/s00277-020-03926-6
PMID:31970447
Abstract

This current study retrospectively analyzed the clinical characteristics of 69 adult patients with acquired pure red cell aplasia (PRCA) including 40 elderly and 29 non-elderly patients from September 2009 to June 2019. The remission induction therapy regimens included cyclosporine A (CsA), corticosteroids (CS), or other immunosuppressive agents. The overall response rate was 55% (22/40) in the elderly group compared with 75.9% (22/29) in non-elderly patients (P = 0.075). In elderly patients, the best remission was achieved in the group treated with CsA than those treated with CS or other immunosuppressive agents (83.3% vs 26.7% vs 42.9%%, P = 0.004). However, outcomes of remission were similar among different treatment groups (P = 0.458) in non-elderly patients. CS induced a higher response rate in the non-elderly than that in the elderly (88.9% vs 26.7%, P = 0.009). By univariate and multivariate analysis, the clinical efficacy of elderly patients with acquired PRCA was closely associated with an induction regimen of CsA (P = 0.009; P = 0.017). In conclusion, CsA might produce higher response rate than CS and other drugs in elderly patients with acquired PRCA.

摘要

本研究回顾性分析了 2009 年 9 月至 2019 年 6 月期间 69 例成人获得性纯红细胞再生障碍性贫血(PRCA)患者的临床特征,包括 40 例老年患者和 29 例非老年患者。缓解诱导治疗方案包括环孢素 A(CsA)、皮质类固醇(CS)或其他免疫抑制剂。老年组的总体缓解率为 55%(22/40),而非老年组为 75.9%(22/29)(P=0.075)。在老年患者中,CsA 治疗组的最佳缓解率优于 CS 或其他免疫抑制剂治疗组(83.3%比 26.7%比 42.9%,P=0.004)。然而,非老年患者中不同治疗组的缓解结果相似(P=0.458)。CS 在非老年患者中的缓解率高于老年患者(88.9%比 26.7%,P=0.009)。单因素和多因素分析显示,老年获得性 PRCA 患者的临床疗效与 CsA 诱导方案密切相关(P=0.009;P=0.017)。总之,CsA 可能在老年获得性 PRCA 患者中产生比 CS 和其他药物更高的缓解率。

相似文献

1
Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective.免疫抑制疗法治疗老年获得性纯红细胞再生障碍:环孢素 A 可能更有效。
Ann Hematol. 2020 Mar;99(3):443-449. doi: 10.1007/s00277-020-03926-6. Epub 2020 Jan 22.
2
Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.成人获得性纯红细胞再生障碍症患者对环孢素 A 和皮质类固醇的反应:单中心连续经验。
Int J Hematol. 2018 Aug;108(2):123-129. doi: 10.1007/s12185-018-2446-y. Epub 2018 Mar 27.
3
Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids.环孢素A与皮质类固醇联合使用可使获得性纯红细胞再生障碍性贫血成年患者更快地诱导完全缓解。
Medicine (Baltimore). 2019 Oct;98(41):e17425. doi: 10.1097/MD.0000000000017425.
4
Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.接受环孢素A治疗的获得性原发性特发性纯红细胞再生障碍性贫血患者的长期预后。日本针对纯红细胞再生障碍性贫血协作研究组开展的一项全国性队列研究。
Haematologica. 2007 Aug;92(8):1021-8. doi: 10.3324/haematol.11192. Epub 2007 Jul 20.
5
[Comparison of Cyclosporine A and Cyclosporine A Combined with Corticosteroid in the Treatment of Acquired Pure Red Cell Aplasia].环孢素A与环孢素A联合皮质类固醇治疗获得性纯红细胞再生障碍性贫血的比较
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1138-1142. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.032.
6
Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.环孢素通过补偿纯红细胞再生障碍性贫血和获得性再生障碍性贫血患者中减少的调节性T细胞来恢复造血功能。
Ann Hematol. 2016 Apr;95(5):771-81. doi: 10.1007/s00277-016-2629-7. Epub 2016 Mar 11.
7
Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.胸腺瘤相关纯红细胞再生障碍性贫血免疫抑制治疗后的长期反应及结局:日本PRCA协作研究组的一项全国性队列研究
Haematologica. 2008 Jan;93(1):27-33. doi: 10.3324/haematol.11655.
8
Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.100 例纯红细胞再生障碍性贫血成年患者的临床特征和结局。
Ann Hematol. 2022 Jul;101(7):1493-1498. doi: 10.1007/s00277-022-04847-2. Epub 2022 Apr 23.
9
The clinical characteristics and therapy response of patients with acquired pure red cell aplasia.获得性纯红细胞再生障碍性贫血患者的临床特征及治疗反应
Hematology. 2018 Oct;23(9):639-645. doi: 10.1080/10245332.2018.1470068. Epub 2018 May 12.
10
Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia.
Leuk Lymphoma. 2001 Nov-Dec;42(6):1339-42. doi: 10.3109/10428190109097761.

引用本文的文献

1
[Nonspecific peripheral T cell lymphoma combined with pure red cell aplasia: a case report and literature review].[非特异性外周T细胞淋巴瘤合并纯红细胞再生障碍性贫血:1例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):359-362. doi: 10.3760/cma.j.cn121090-20240809-00297.
2
Clinical features and outcomes in large granular lymphocyte leukemia - associated pure red cell aplasia with STAT3 mutation.伴有STAT3突变的大颗粒淋巴细胞白血病相关纯红细胞再生障碍性贫血的临床特征与转归
Ann Hematol. 2025 Apr;104(4):2351-2360. doi: 10.1007/s00277-025-06371-5. Epub 2025 Apr 23.
3
Mutational heterogeneities in STAT3 and clonal hematopoiesis-related genes in acquired pure red cell aplasia.
获得性纯红细胞再生障碍性贫血中STAT3及克隆性造血相关基因的突变异质性
Ann Hematol. 2025 Mar;104(3):1471-1479. doi: 10.1007/s00277-025-06356-4. Epub 2025 Apr 9.
4
Efficacy and influencing factors of immunosuppressive therapy for pure red cell aplasia: meta-analysis and systematic review.纯红细胞再生障碍性贫血免疫抑制治疗的疗效及影响因素:荟萃分析与系统评价
Ann Hematol. 2025 Apr;104(4):2189-2206. doi: 10.1007/s00277-025-06315-z. Epub 2025 Mar 19.
5
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib.伴有 T 细胞大颗粒淋巴细胞白血病的难治性纯红细胞再生障碍性贫血经芦可替尼治疗。
Ann Hematol. 2024 Aug;103(8):3239-3242. doi: 10.1007/s00277-024-05856-z. Epub 2024 Jun 27.
6
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.预测环孢素治疗纯红细胞再生障碍性贫血患者疗效的列线图模型。
Ann Hematol. 2024 Jun;103(6):1877-1885. doi: 10.1007/s00277-024-05636-9. Epub 2024 Feb 3.
7
Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.100 例纯红细胞再生障碍性贫血成年患者的临床特征和结局。
Ann Hematol. 2022 Jul;101(7):1493-1498. doi: 10.1007/s00277-022-04847-2. Epub 2022 Apr 23.
8
[Clinical analysis of 67 cases of pure red cell aplastic anemia].67例纯红细胞再生障碍性贫血的临床分析
Zhonghua Xue Ye Xue Za Zhi. 2020 Jun 14;41(6):506-510. doi: 10.3760/cma.j.issn.0253-2727.2020.06.013.